TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

Reset
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
CLOV Wai Conrad CEO, Counterpart Health 09/15/2026 Verkauf 4.72 300,000 1,416,000 Form 4
CLOV Soares Karen Chief Legal Officer 09/15/2026 Verkauf 4.78 6,846 32,724 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 09/15/2026 Verkauf 4.78 9,273 44,325 Form 4
CLOV Oldakowski Joseph Frank VP OF FINANCE AND CONTROLLER 09/14/2026 Verkauf 5.16 20,000 103,200 Form 4
CLOV Thornton Joseph Clay Interim CFO 08/17/2026 Verkauf 4.39 17,775 78,032 Form 4
CLOV Soares Karen Chief Legal Officer 08/12/2026 Zuteilung 108,695 Form 4
CLOV Thornton Joseph Clay Interim CFO 08/12/2026 Zuteilung 54,347 Form 4
CLOV Toy Andrew Chief Executive Officer 08/10/2026 Verkauf 4.65 87,798 408,261 Form 4
CLOV Soares Karen Chief Legal Officer 07/20/2026 Verkauf 4.51 51,700 233,167 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 07/17/2026 Verkauf 4.53 4,839 21,921 Form 4
CLOV Toy Andrew Chief Executive Officer 07/15/2026 Verkauf 4.67 62,711 292,860 Form 4
CLOV Wai Conrad CEO, Counterpart Health 07/15/2026 Verkauf 4.67 24,215 113,084 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 07/15/2026 Verkauf 4.67 13,119 61,266 Form 4
CLOV Soares Karen Chief Legal Officer 07/15/2026 Verkauf 4.67 10,519 49,124 Form 4
CLOV Thornton Joseph Clay Interim CFO 07/15/2026 Verkauf 4.67 4,630 21,622 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 07/08/2026 Verkauf 4.68 2,384 11,157 Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?